Cargando…
Novel siRNA formulation to effectively knockdown mutant p53 in osteosarcoma
OBJECTIVES: The tumor suppressor p53 plays a crucial role in the development of osteosarcoma. The primary objective of this study is to develop and optimize lipid based nanoparticle formulations that can carry siRNA and effectively silence mutant p53 in 318–1, a murine osteosarcoma cell line. METHOD...
Autores principales: | Kundu, Anup K., Iyer, Swathi V., Chandra, Sruti, Adhikari, Amit S., Iwakuma, Tomoo, Mandal, Tarun K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479560/ https://www.ncbi.nlm.nih.gov/pubmed/28636657 http://dx.doi.org/10.1371/journal.pone.0179168 |
Ejemplares similares
-
A novel link between the HER2-Akt and MDM2-p53 pathways via CSN6
por: Iyer, Swathi V., et al.
Publicado: (2012) -
Allele-specific silencing of mutant p53 attenuates dominant-negative and gain-of-function activities
por: Iyer, Swathi V., et al.
Publicado: (2015) -
Targeting Oncogenic Mutant p53 for Cancer Therapy
por: Parrales, Alejandro, et al.
Publicado: (2015) -
Regulators of Oncogenic Mutant TP53 Gain of Function
por: Yamamoto, Satomi, et al.
Publicado: (2018) -
MTBP suppresses cell migration and filopodia formation by inhibiting ACTN4
por: Agarwal, Neeraj, et al.
Publicado: (2012)